Effect of Cryptococcus neoformans on the immune system of immunocompetent patients

J. Wang, Y. Luo, X. Wei, Y. Zai, S. Li (Guangzhou, China)

Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Session: Prognostic indices in respiratory infections
Session type: Thematic Poster Session
Number: 2516
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Abstract

On one hand the host immune system regulates the susceptibility and resistance to cryptococcal infection, on the other Cn can also affect T-cell activation and polarization during infection. Cn may potentially interfere with the differentiation of Th1 cells, which may be an escape mechanism of evade host defence and contribute to the cryptococcal infection in immunocompetent paients. However, most of these effects on T-cell biology were only found in cell and animal studies so far. Objectives: to determine the effect of Cn on the immune system of immunocompetent patients. Methods Twenty immunocompetent patients with pulmonary cryptococcal infection were enrolled. Blood plasma concentrations of IFN-γ, IL-4 and IL-12 were measured using Elisa. PBMC were then isolated and incubated with or without IL-12 for 48 hours, followed by the assay of IFN-γ and IL-4 concentration in the supernatant. Results plasma IFN-γ was greatly decreased in the patients when compared to the healthy controls. No significant differences in plasma IL-4 and IL-12 were observed. Although IL-12 treatment can both increase IFN-γ level in PBMC culture supernatant from the two groups, the increment for cryptococcal infection patients was much lower(3.1-fold) compared with that from healthy control(7.4-fold). IL-12 treatment had no observed effect on the IL-4 production of PBMC. Conclusions cryptococcal infection can damage the host immune system, leading to a deficient response to the IL-12 stimulation and an impaired Th1 polarization. This may explain the persistence of Cn in the immunocompetent patients.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Wang, Y. Luo, X. Wei, Y. Zai, S. Li (Guangzhou, China). Effect of Cryptococcus neoformans on the immune system of immunocompetent patients. Eur Respir J 2012; 40: Suppl. 56, 2516

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Whole Exome Sequencing study in a subgroup of sarcoidosis patients presenting an opportunistic infection with Cryptococcus neoformans.
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020


In vivo evidence for aspergillus fumigatus and pseudomonas aeruginosa driven th-17 type inflammatory responses in the lungs of CF-patients
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009


Effects of PC945, a novel antifungal agent optimised for lung delivery, on Candida albicans lung infection in mice
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020


Treatment outcome in patients with chronic pulmonary aspergillosis by azole-resistant aspergillus fumigatus
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016


Influence of candida species fungi on growth and pathogenicity of mycobacteria tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 663s
Year: 2007

Characteristics of mycobacterial strains isolated from immunocompetent and immunosuppressed patients with particular forms of tuberculosis
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007


The role of ceramide in the host defense against pseudomonas aeruginosa infection
Source: Eur Respir J 2006; 28: Suppl. 50, 486s
Year: 2006

Serologic immunoglobulin E responses against Aspergillus and Candida in patients with chronic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 280s
Year: 2005

Estimation immune and cytokine status of children infected M.tuberculosis
Source: Annual Congress 2008 - Specific tuberculosis management problems in children and adolescents
Year: 2008

Increased Th2 response with C. pneumoniae infection
Source: Eur Respir J 2002; 20: Suppl. 38, 311s
Year: 2002

Disseminated Talaromyces marneffei and Mycobacterium avium coinfection accompanied sweet syndrome in a patient with anti-interferon-gamma autoantibody
Source: International Congress 2019 – Pulmonary vascular diseases?
Year: 2019

Mycobacterium tilburgii infection in an HIV-seropositive host
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009


Nocardia community-acquired pneumonia in immunocompetent and immunocompromised host
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009


Organism endocrine and immune system status depending on tuberculosis infection course
Source: Eur Respir J 2002; 20: Suppl. 38, 366s
Year: 2002

LSC Abstract – The host genetic background impacts on pseudomonas aeruginosa-induced T cell responses and individual susceptibility/resistance to respiratory infection
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Year: 2015

Clinicopathologic features of pulmonary Cryptococcus
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017

Induction of innate immune response in fresh human lung tissue ex vivo following P. aeruginosa infection
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018


Penicillium marneffei presenting as an obstructing endobronchial lesion in an immunocompetent host
Source: Eur Respir J 2012; 39: 1540-1543
Year: 2012


Impaired host defense against Mycobacterium avium in mice with chronic granulomatous disease
Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Year: 2008


Cryptococcus infections in cardiothoracic transplant recipients – a variable journey
Source: Virtual Congress 2021 – Challenging problems in lung transplantation
Year: 2021